BCOMF yields 193.26% · JNJ yields 2.14%● Live data
📍 BCOMF pulled ahead of the other in Year 1
Combined, BCOMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BCOMF + JNJ for your $10,000?
B Communications Ltd., through its subsidiaries, provides a range of telecommunications services for business and private customers in Israel. The company offers landline communication services, mobile telephone radio services, data transmission and communication services, international communication services, multi-channel satellite and network television services, Internet infrastructure and access services, call center services, and maintenance and development of communications infrastructure services. It also engages in the provision of communications services to other communications providers, including wholesale market services, distribution of television and radio broadcasts, and supply and maintenance of equipment and services in customer premises. The company was formerly known as 012 Smile. Communications Ltd. and changed its name to B Communications Ltd. in March 2010. B Communications Ltd. was incorporated in 1999 and is based in Tel Aviv-Yafo, Israel.
Full BCOMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.